Lancet 330(8571):13001304 Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B et al (2020) Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5
Before taking this medicine, let your doctor know if you have kidney stones or any other kidney problems, as it can cause an increase in the amount of calcium in blood or urine
For patients who can pursue both, combining them in a structured protocol produces results that neither achieves alone because structural repair runs better when cellular energy is restored
BPI recommends a minimum 6-8 week protocol for optimal results
Your membership invoice is charged on the same date each month, based on when you first signed up
As you may know from the popularity of Ozempic and other GLP-1 agonist medicines, these hormones help regulate appetite and metabolism